Home LiteratureArticle Details
PMID: 7536098 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs.

British journal of pharmacology ·Vol. 114 ·No. 1 ·1995-01-00 ·Pages 93-8

Banner KH, Page CP

Abstract

1. The aims of this study were to determine which phosphodiesterase (PDE) isoenzymes are involved in the control of eosinophil accumulation in the airways of ovalbumin (OVA)-immunized guinea-pigs by the use of isoenzyme selective inhibitors and to compare the effects of acute versus chronic administration of PDE isozyme inhibitors on pulmonary cell influx in ovalbumin-immunized guinea-pigs. 2. Guinea-pigs were sensitized and subsequently challenged with aerosolized OVA. Twenty four hours later bronchoalveolar lavage (BAL) was performed to permit assessment of inflammatory cell accumulation. A significant increase in the number of eosinophils was observed in the lavage fluid from OVA-immunized (13.6 +/- 1.4 x 10(4) ml-1 in acute experiments and 10.1 +/- 1.4 x 10(4) ml-1 in chronic experiments) animals compared with sham-treated controls (5.6 +/- 0.6 x 10(4) ml-1 in acute experiments and 5.1 +/- 0.6 x 10(4) ml-1 in chronic experiments). There was no difference in neutrophil, mononuclear cell or total cell numbers between the two groups. 3. Acute administration of a high dose of selective and non-selective PDE inhibitors by the i.p. route had no significant effect on eosinophil accumulation in the airways. 4. Chronic administration of a low dose (3 mg kg-1, i.p., twice daily for 7 days) of the type IV PDE inhibitor, RO 20-1724, and the PDE III/IV inhibitor, zardaverine, produced a significant inhibition of eosinophil accumulation (46% and 59% respectively). 5. These results suggest that the type IV PDE isoenzyme plays a role in the control of allergen-induced eosinophil infiltration into the airways, but indicate that a period of low dose chronic treatment with a type IV or mixed type III/IV PDE inhibitor is necessary for eosinophil accumulation in the airways to be reduced.

MeSH Terms
1-Methyl-3-isobutylxanthine/pharmacology Allergens Animals Guinea Pigs Inflammation Male Ovalbumin/drug effects Phosphodiesterase Inhibitors/pharmacology Phosphoric Diester Hydrolases/metabolism,pharmacology Pulmonary Alveoli/drug effects Vinca Alkaloids/pharmacology
Chemicals
Allergens Phosphodiesterase Inhibitors Vinca Alkaloids vinpocetine Ovalbumin Phosphoric Diester Hydrolases 1-Methyl-3-isobutylxanthine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Banner K H
Department of Pharmacology, King's College, London.
Page C P
References (29)
29 references, click to expand
  1. Pharmacologic management of reversible obstructive airways disease.
    Med Clin North Am. 1981 May;65(3):579-613 PMID: 6787350
  2. Cyclic adenosine 3':5'-monophosphate phosphodiesterase. Distinct forms in human lymphocytes and monocytes.
    J Biol Chem. 1976 Aug 25;251(16):4922-9 PMID: 182685
  3. The eosinophil and the pathophysiology of asthma.
    J Allergy Clin Immunol. 1986 Apr;77(4):527-37 PMID: 3514730
  4. Overview of effects of theophylline.
    J Allergy Clin Immunol. 1986 Oct;78(4 Pt 2):780-7 PMID: 2877016
  5. The effects of theophylline on airway inflammation.
    Chest. 1987 Jul;92(1 Suppl):32S-37S PMID: 3297525
  6. The role of the eosinophil in the pathogenesis of asthma.
    Allergy. 1987 Jul;42(5):321-35 PMID: 3307515
  7. Effect of theophylline and adenosine on eosinophil function.
    Am Rev Respir Dis. 1989 Aug;140(2):327-33 PMID: 2548425
  8. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Biochem Pharmacol. 1990 Jan 1;39(1):75-84 PMID: 2153383
  9. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide.
    J Immunol. 1990 Apr 1;144(7):2558-65 PMID: 2108206
  10. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.
    Trends Pharmacol Sci. 1991 Jan;12(1):19-27 PMID: 1848733
  11. Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes.
    Biochem Pharmacol. 1991 Jul 25;42(4):869-77 PMID: 1651080
  12. Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation.
    Biochem Pharmacol. 1991 Jul 25;42(4):937-45 PMID: 1651083
  13. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
    Thorax. 1991 Jul;46(7):512-23 PMID: 1877039
  14. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.
    Br J Pharmacol. 1991 Jun;103(2):1339-46 PMID: 1653070
  15. Effects of theophylline compared with prednisolone on late phase airway leukocyte infiltration in guinea pigs.
    Int Arch Allergy Appl Immunol. 1991;94(1-4):293-4 PMID: 1937894
  16. Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP.
    J Appl Physiol (1985). 1992 Jan;72(1):389-95 PMID: 1311292
  17. Zardaverine: a cyclic AMP specific PDE III/IV inhibitor.
    Agents Actions Suppl. 1991;34:379-402 PMID: 1665311
  18. Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma.
    Clin Exp Allergy. 1992 Mar;22(3):337-44 PMID: 1316796
  19. Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?
    Biochem Pharmacol. 1992 May 28;43(10):2041-51 PMID: 1318047
  20. Theophylline--an immunomodulatory role in asthma?
    Am Rev Respir Dis. 1993 Mar;147(3):518-23 PMID: 8442581
  21. Role of phosphodiesterases in the regulation of endothelial permeability in vitro.
    J Clin Invest. 1993 Apr;91(4):1421-8 PMID: 8386187
  22. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
    J Pharmacol Exp Ther. 1993 Jul;266(1):306-13 PMID: 8392555
  23. Isbufylline, a new xanthine derivative, inhibits airway hyperresponsiveness and airway inflammation in guinea pigs.
    Eur J Pharmacol. 1993 Nov 16;249(3):251-7 PMID: 7507057
  24. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma.
    Lancet. 1994 Apr 23;343(8904):1006-8 PMID: 7909049
  25. Effects of rolipram on responses to acute and chronic antigen exposure in monkeys.
    Am J Respir Crit Care Med. 1994 May;149(5):1153-9 PMID: 8173755
  26. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.
    Pulm Pharmacol. 1994 Feb;7(1):1-17 PMID: 8003849
  27. Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea-pig.
    Br J Pharmacol. 1994 May;112(1):332-40 PMID: 8032659
  28. Total eosinophil counts in the management of bronchial asthma.
    N Engl J Med. 1975 May 29;292(22):1152-5 PMID: 1124105
  29. Cyclic nucleotides and their relationship to complement-component-C2 synthesis by human monocytes.
    Biochem J. 1984 Sep 1;222(2):477-86 PMID: 6089769
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1995-01-00
Pages
93-8
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1510161
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]